KEYTRUDA is an immunotherapy that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, helping the immune system to help detect and fight cancer cells.
Funding from the ALS Association and the Tow Foundation will be used by the New York Genome Center to determine the entire genetic sequence of people with ALS who donated their tissues after death.
Kyle Allison, recipient of the NIH Director’s Early Independence Award, is exploring how to keep common bacterial infections from becoming chronic illnesses.
Columbia participated in the study based on serial scans of more than 1,700 pregnancies. The study was published online in the American Journal of Obstetrics and Gynecology.
In celebration of its 50th anniversary, the National Endowment for the Humanities identified Rita Charon’s narrative medicine grant as one that enriched and shaped American lives.
